Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631241 · ClinicalTrials.gov registry record · NA
Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00631241: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00631241 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00631241, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if the parametrial nodes are "sentinel" nodes (the lymph nodes believed to be the greatest risk for the spread of cancer) and if intraoperative lymphatic mapping can identify "sentinel" lymph nodes in the parametrium (the tissue that is on either side of the cervix). Identifying these lymph nodes may help to predict the status of the remaining lymph nodes in the pelvis. This research will also determine if India Ink is safe to use with the blue dye and radioactive tracer and if it improves the process of identifying the sentinel nodes.
Interventions
- PROCEDURE Single Photon Emission Computed Tomography
- PROCEDURE Intraoperative Lymphatic Mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631241
The ClinicalTrials.gov registry entry for NCT00631241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Single Photon Emission Computed Tomography is the first listed.
NCT00631241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631241 about?
NCT00631241 is a clinical study titled "Analysis of Parametrial Lymph Nodes as Sentinel Nodes in Patients With Cervical Cancer". The goal of this clinical research study is to find out if the parametrial nodes are "sentinel" nodes (the lymph nodes believed to be the greatest risk for the spread of cancer) and if intraoperative lymphatic mapping can identify "sentinel" lymph nodes in the parametrium (the tissue that is on eith...
What is the current status of trial NCT00631241?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00631241?
The interventions under investigation include: Single Photon Emission Computed Tomography (PROCEDURE), Intraoperative Lymphatic Mapping (PROCEDURE).
Who is sponsoring clinical trial NCT00631241?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.